<SEC-DOCUMENT>0001213900-23-060074-index.html : 20230726
<SEC-HEADER>0001213900-23-060074.hdr.sgml : 20230726
<ACCEPTANCE-DATETIME>20230726171554
ACCESSION NUMBER:		0001213900-23-060074
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		9
CONFORMED PERIOD OF REPORT:	20230726
FILED AS OF DATE:		20230726
DATE AS OF CHANGE:		20230726

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nano-X Imaging Ltd.
		CENTRAL INDEX KEY:			0001795251
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39461
		FILM NUMBER:		231114533

	BUSINESS ADDRESS:	
		STREET 1:		COMMUNICATIONS CENTER
		CITY:			NEVE ILAN
		STATE:			L3
		ZIP:			9085000
		BUSINESS PHONE:		972-02-547-6333

	MAIL ADDRESS:	
		STREET 1:		COMMUNICATIONS CENTER
		CITY:			NEVE ILAN
		STATE:			L3
		ZIP:			9085000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea182344-6k_nanoximaging.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: ea182344-6k_nanoximaging.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea182344ex4-1_nanoximaging.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT, DATED JULY 23, 2023, BETWEEN NANO-X IMAGING LTD AND A.G.P./ALLIANCE GLOBAL PARTNERS
<TEXT>
Document 2 - file: ea182344ex4-1_nanoximaging.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea182344ex4-2_nanoximaging.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT, DATED JULY 23, 2023, BETWEEN NANO-X IMAGING LTD AND THE PURCHASERS IDENTIFIED THEREIN
<TEXT>
Document 3 - file: ea182344ex4-2_nanoximaging.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ea182344ex4-3_nanoximaging.htm
<DESCRIPTION>FORM OF WARRANT
<TEXT>
Document 4 - file: ea182344ex4-3_nanoximaging.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ea182344ex5-1_nanoximaging.htm
<DESCRIPTION>OPINION OF FISCHER (FBC & CO.)
<TEXT>
Document 5 - file: ea182344ex5-1_nanoximaging.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>6
<FILENAME>ea182344ex5-2_nanoximaging.htm
<DESCRIPTION>OPINION OF MAYER BROWN LLP
<TEXT>
Document 6 - file: ea182344ex5-2_nanoximaging.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: ex5-1_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex5-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 8 - file: ex5-1_002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 9 - file: image_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>